Fulgent Genetics Inc
NASDAQ:FLGT
Fulgent Genetics Inc
NASDAQ:FLGT
Price:
21.74 USD
-1.67%
Market Closed
Updated:
May 21, 2024
Fulgent Genetics Inc
Operating Expenses
|
Fulgent Genetics Inc
Operating Expenses Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Fulgent Genetics Inc
NASDAQ:FLGT
|
Operating Expenses
-$300.4m
|
CAGR 3-Years
-72%
|
CAGR 5-Years
-80%
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Operating Expenses
-$2.3B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-3%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Operating Expenses
-$1.8B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
0%
|
|
|
CVS Health Corp
NYSE:CVS
|
Operating Expenses
-$40.1B
|
CAGR 3-Years
24%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-10%
|
|
|
Cigna Corp
NYSE:CI
|
Operating Expenses
-$16.2B
|
CAGR 3-Years
53%
|
CAGR 5-Years
25%
|
CAGR 10-Years
6%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Operating Expenses
-$2.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-7%
|
See Also
What is Fulgent Genetics Inc's Operating Expenses?
Operating Expenses
-300.4m
USD
-300.4m
USD
Based on the financial report for Mar 31, 2024, Fulgent Genetics Inc's Operating Expenses amounts to -300.4m USD.
What is Fulgent Genetics Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-80%
-80%
Over the last year, the Operating Expenses growth was -57%. The average annual Operating Expenses growth rates for Fulgent Genetics Inc have been -72% over the past three years , -80% over the past five years .
You don't have any saved screeners yet
